Pax: Developmental control genes in cell growth and differentiation

Cell Growth and Differentiation

Volumn 7, Issue 3, 1996, Pages 405-412

  Stuart, Edward T ^a   Gruss, Peter ^a  

^a MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; EMBRYO DEVELOPMENT; GENE REPRESSION; GLIOBLASTOMA; HUMAN; MEDULLOBLASTOMA; NONHUMAN; PRIORITY JOURNAL; RHABDOMYOSARCOMA; TRANSCRIPTION REGULATION;

ANIMALS; B-CELL-SPECIFIC ACTIVATOR PROTEIN; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REGULATOR; HUMANS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS;

EID: 0029842892     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Kessel, M, and Gruss, P. Murine developmental control genes. Science (Washington DC), 249: 374-379, 1990.
2. Krumlauf, R. Hox genes in vertebrate development. Cell, 78: 191-201, 1994.
3. Joyner, A. L., Kornberg, T., Coleman, K. G., Cox, D. R., and Martin, G R. Expression during embryogenesis of a mouse gene with sequence homology to the Drosophila engrailed gene. Cell, 43: 29-37, 1985.
4. Joyner, A. L., and Martin, G. R. En-1 and En-2, two mouse genes with sequence homology to the Drosophila engrailed gene: expression during embryogenesis. Genes & Dev., 1: 29-38, 1987.
5. Stuart, E. T , Kioussi, C., and Gruss, P. Mammalian PAX genes. Annu. Rev Genet., 28: 219-236, 1994.
6. Stuart, E. T., and Gruss, P PAX: What's new in cancer and development? Hum. Mol. Genet., 4: 1717-1720, 1995.
7. Nusse, R., and Varmus, H. E. Wnt genes. Cell, 69- 1073-1087, 1992.
8. Ullrich, A., and Schlessinger, J. Signal transduction by receptors with tyrosine kinase activity. Cell, 61: 203-212, 1990.
9. Yamada, G., Sugimura, K., and Stuart, E T. Gene targeting approaches in the study of cellular processes involved in growth or differentiation: advances in the analysis of oncogenes, tumour suppressor genes, cytokine receptor systems and developmental control genes. Eur. J. Biochem., 226: 739-749, 1994.
10. Urbanék, P., Wang, Z-Q., Fetka, I., Wagner, E. F., and Busslinger. M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell, 79: 901-912, 1994.
11. Halder, G., Callaerts, P., and Gehring, W. J. Induction of ectopic eyes by targeted expression of the eyeless gene in Drosophila. Science (Washington DC), 267. 1788-1792, 1995.
12. Quiring, R., Walldorf, U., Kloter, U., and Gehring, W. J. Homology of the eyeless gene of Drosophila to the small eye gene in mice and Anindia in humans. Science (Washington DC), 265. 785-789, 1994.
13. Chalepakis, G., Tremblay, P , and Gruss, P Pax genes, mutants and molecular function. J. Cell Sci., 16: 61-67, 1992.
14. Gruss, P., and Walther, C. Pax in development. Cell, 69: 719-22, 1992.
15. Chalepakis, G., Stoykova, A., Wijnholds, J., Tremblay, P., and Gruss, P. Pax: gene regulators in the developing central nervous system. J. Neurobiol., 24: 1367-1384. 1993.
16. Noll, M. Evolution and role of Pax genes. Curr. Opin. Genet. Dev., 3: 595-605, 1993.
17. Stapleton, P., Weith, A., Urbanek, P., Kozmik, Z., and Busslinger, M. Chromosomal localization of seven PAX genes and cloning of a novel family member, PAX-9. Nat. Genet., 3: 292-298, 1993.
18. Pilz, A. J., Povey, S., Gruss, P., and Abbott, C. M. Mapping of the human homologs of the murine paired-box-containing genes Mamm Genome, 4: 78-82, 1993.
19. Walther, C., Guénet, J-L., Simon, D., Deutsch, U., Jostes, B , Goulding, M., Plachov, D., Balling, R., and Gruss, P. Pax: a murine multigene family of paired box containing genes. Genomics, 11: 424-434, 1991.
20. Dressier, G. R., and Douglass, E. C. Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc. Natl. Acad. Sci USA, 89: 1179-1183, 1992.
21. Zannini, M , Francis Lang, H., Plachov, D., and Di Lauro, R. Pax-8, a paired domain-containing protein, binds to a sequence overlapping the recognition site of a homeodomain and activates transcription from two thyroid-specific promoters. Mol. Cell. Biol., 12, 4230-4241, 1992.
22. Czerny, T , Schaffner, G., and Busslinger, M. DNA sequence recognition by Pax proteins: bipartate structure of the paired domain and its binding site. Genes & Dev., 7: 2048-2061. 1993
23. Chalepakis, G., Fritsch, R., Fickenscher, H., Deutsch, U , Goulding, M., and Gruss, P. The molecular basis of the undulated/Pax-1 mutation. Cell, 66: 873-884, 1991.
24. Chalepakis, G., Wijnholds, J., and Gruss, P. Pax-3-DNA interaction: flexibility in the DNA binding and induction of DNA conformational changes by paired domains. Nucleic Acids Res., 22: 3131-3137, 1994.
25. Adams, B., Dörfler, P., Kozmik, A. A. Z., Urbänek, P., Maurer-Fogy, I., and Busslinger, M. Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes & Dev., 6: 1589-1607, 1992
26. Treisman, J., Harris, E., and Desplan, C. The paired box encodes a second DNA-binding domain in the Paired homeo domain protein. Genes & Dev., 5: 594-604, 1991.
27. Treisman, J., Gönczy, P., Vashishita, M., Harns, E., and Desplan, C. A single amino acid can determine the DNA binding specificity of homeodomain proteins. Cell, 59: 553-562, 1989.
28. Kozmik, Z., Wang, S., Dörfler, P., Adams, B., and Busslinger, M. The promoter of the CD19 gene is a target for the B-cell specific transcription factor BSAP. Mol. Cell. Biol., 12: 2662-2672, 1992.
29. Okabe, T., Watanabe, T , and Kudo, A. A pre-B- and B cell-specific DNA-binding protein, EBB-1, which binds to the promoter of the VpreB1 gene. Eur. J Immunol., 22: 37-43, 1992.
30. Liao, F., Giannini, S. L, and Birshtein, B. K. A nuclear DNA-binding protein expressed during early stages of B cell differentiation interacts with diverse segments within and 3′ of the lg H chain gene cluster. J. Immunol., 148: 2909-2917, 1992.
31. Rothman, P., Li, S. C., Gorham, B., Glimcher, L., Alt, F., and Boothby, M. Identification of a conserved lipopolysaccaride-plus-Interleukin-4-responsive element located at the promoter of germ line ε transcripts. Mol. Cell. Biol., 11: 5551-5561, 1991.
32. Singh, M., and Birshtein, B. K NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3′ alpha enhancer at early stages of B-cell differentiation. Mol Cell. Biol., 13: 3611-3622, 1993.
33. Waters, S. H., Saikh, K. U., and Stavnezer, J. A B-cell-specific nuclear protein that binds to DNA sites 5′ to immunoglobulin Sα tandem repeats is regulated during differentiation. Mol. Cell. Biol., 9: 5594-5601, 1989
34. Xu, L., Kim, M. G., and Marcu, K B. Properties of B cell stage specific and ubiquitous nuclear factors binding to immunoglobulin heavy chain gene switch regions. Int. Immunol., 4: 875-887, 1992.
35. Barberis, A., Superti-Furga, G., Vitelli, L, Kemler, I., and Busslinger, M. Developmental and tissue-specific regulation of a novel transcription factor of the sea urchin. Genes & Dev., 3: 663-675, 1989.
36. Stoykova, A. S., and Gruss, P Roles of Pax genes in developing and adult brain as suggested by expression patterns. J. Neurosci., 14: 1395-1412, 1994.
37. Deutsch, U., Dressler, G. R., and Gruss, P. Pax1, a member of a paired box homologous murine gene family, is expressed in segmented structures during development Cell, 53: 617-625, 1988
38. Dressier, G. R., Deutsch, U., Chowdhury, K., Nornes, H. O., and Gruss, P Pax2, a new murine paired-box-containing gene and its expression in the developing excretory system Development (Camb.), 109: 787-795, 1990.
39. Phelps, D. E., and Dressier, G. R. Aberrant expression of Pax-2 in Danforth's short tail (Sd) mice. Dev. Biol., 157: 251-258, 1993.
40. Poleev, A., Fickenscher, H., Mundlos, S., Winterpacht, A., Zabel, B , Fidler, A , Gruss, P., and Plachov, D PAX8, a human paired box gene: isolation and expression in developing thyroid, kidney and Wilms'tumor. Development (Camb.), 116: 611-623, 1992.
41. Kozmik, Z., Kurzbauer, R., Dörfler, P., and Busslinger, M Alternative splicing of Pax-8 gene transcripts is developmentally regulated and generates isoforms with different transactivation properties Mol. Cell. Biol., 13: 6024-6035, 1993
42. Maulbecker, C. C., and Gruss, P. The oncogenic potential of Pax genes. EMBO J., 12: 2361-2397, 1993
43. Bigner, S. H., Mark, J., Burger, P. C., Mahaley, M. S , Bullard, D. S., Muhlbaier, L. H., and Bigner, D. D. Specific chromosomal abnormalities in malignant human gliomas. Cancer Res., 48: 405-411, 1988.
44. Bigner, S. H., Mark, J., Bullard, D. E., Mahaley, M. S., Jr., and Bigner, D. D. Chromosomal evolution in malignant human gliomas starts with specific and usually numerical deviations Cancer Genet. Cytogenet, 22: 121-135, 1986.
45. Collins, V. P., and James, C. D. Gene and chromosomal alterations associated with the development of human gliomas. FASEB J., 7: 926-930, 1993.
46. James, C. D., Carlbom, E., Dumanski, J. P., Hansen, M , Nordenskjold, M., Collins, V. P , and Cavanee, W. K. Clonal genomic alterations in glioma malignancy stages Cancer Res., 48: 5546-5551, 1988.
47. Rey, J. A., Bello, M. J , de Campos, J. M., Kusak, M. E., Ramos, C., and Benitez, J Chromosomal patterns in human malignant astrocytomas. Cancer Genet. Cytogenet., 29: 201-221, 1987
48. Reifenberger, G., LIU, L., Ichimura, K., Schmidt, E. E., and Collins, V. P. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res., 53:2736-2739, 1993.
49. James, C. D., Carlbom, E., Nordenskjold, M., Collins, V. P., and Cavanee, W. K. Mitotic recombination of chromosome 17 in astrocytomas. Proc. Natl. Acad. Sci. USA, 86: 2858-2862, 1989.
50. Fults, D., Brockmeyer, D., Tullous, M. W., Pedone, C. A., and Cawthon, R. M. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res., 52: 674-679, 1992.
51. Humphrey, P. A., Wong, A. J., Vogelstein, B., Friedman, H. S., Werner, M. H., Bigner, D. D., and Bigner, S. H. Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. Cancer Res., 48: 2231-2238, 1988.
52. Wong, A J., Ruppert, J. M., Bigner, S. H., Grzeschik, C. H., Humphrey, P. A., Bigner, D. S., and Vogelstein, B. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc. Natl. Acad. Sci. USA, 89: 2965-2969, 1992.
53. Cannon-Albright, L. A., Goldgar, D. E., Meyer, L. J., Lewis, C M., Anderson, D. E., Fountain, J. W., Hegi, M. E., Wiseman, R. W., Petty, E M., Bale, A. E., Olopade, O I , Diaz, M. O., Kwiatkowski, D. J., Piepkorn, M. W., Zone, J. J., and Skolnick, M. H. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science (Washington DC), 258: 1148-1152, 1992.
54. Kamb, A., Shattuck-Eidens, D., Eeles, R., Liu, Q., Gruis, N. A., Ding, W., Hussey, C., Tran, T., Miki, Y., Weaver-Feldhus, J., McClure, M., Aitken, J. F , Anderson, D. E., Bergman, W., Frants, R., Goldgar, D. E., Green, A., MacLennan, R., Martin, N. G., Meyer, L. J., Youl, P., Zone, J. J., Skolnick, M. H., and Cannon-Albright, L. A. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat. Genet., 8: 22-26, 1994.
55. Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Tucker, M A , and Dracopoli, N C. Germline mutations in familial melanoma Nat. Genet., 8: 15-21, 1994.
56. Stuart, E. T., KIOUSSI, C., Aguzzi, A., and Gruss, P. PAX5 expression correlates with increasing malignancy in human astrocytomas Clin. Cancer Res., 1: 207-214, 1995.
57. Stuart, E. T., Haffner, R , Oren, M., and Gruss, P. Loss of p53 function through PAX-mediated transcriptional repression. EMBO J., 14: 5638-5645, 1995.
58. Tuck, S P., and Crawford, L. Characterization of the human p53 gene promoter. Mol. Cell. Biol., 9: 2163-2172, 1989.
59. Schmid, P., Lorenz, A , Hameister, H., and Montenarh, M. Expression of p53 during mouse embryogenesis. Development (Camb.), 113: 857-865, 1991.
60. Aloni-Grinstein, R., Zan-Bar, I., Alboum, I., Goldfinger, N., and Rotter, V. Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage. Oncogene, 8: 3297-3305, 1993.
61. Donehower, L. A., Harvey, M , Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmental normal but susceptible to spontaneous tumours. Nature (Lond.), 356: 215-221, 1992.
62. Armstrong, J. F., Kaufman, M. H., Harrison, D. J., and Clarke, A. R. High-frequency developmental abnormalities in p53-deficient mice. Curr. Biol., 5: 931-936, 1995.
63. Sah, V. P., Attardi, L. D., Mulligan, G. J., Williams, B. O., Bronson, R. T., and Jacks, T. A subset of p53-deficient embryos exhibit exencephaly. Nat. Genet., 10: 175-180, 1995.
64. Bailey, P., and Cushing, H. Medulloblastoma cerebelli: a common type of midcerebellar tumor of childhood. Arch. Neurol. Psychiatry, 14: 192-224, 1925.
65. Kozmik, Z., Sure, U., Rüedi, D., Busslinger, M., and Aguzzi, A. Deregulated expression of PAX-5 in medulloblastoma. Proc. Natl. Acad. Sci. USA, 92: 5709-6713, 1995.
66. Saylors, R. L., III, Sidransky, D., Friedman, H. S., Bigner, S. H., Bigner, D. D., Vogelstein, B., and Brodeur, G. M Infrequent p53 gene mutations in medulloblastomas. Cancer Res., 51: 4721-4723, 1991.
67. Adesina, A. M., Nalbantoglu, J., and Cavenee, W. K. p63 gene mutation and mdm2 gene amplification are uncommon in medulloblastoma. Cancer Res., 54: 5649-5651, 1994.
68. Hastie, N. D. The genetics of Wilms' tumor - a case of disrupted development Annu. Rev. Genet., 28: 523-588, 1994.
69. Rauscher, F. J., Morris, J. F., Tournay, O E., Cook, D. M., and Curran, T. Binding of the Wilms'tumor locus zinc finger protein to the EGR-1 consensus sequence. Science (Washington DC), 250: 1259-1262, 1990.
70. Rauscher, F. J. The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J., 7: 896-903, 1993.
71. Pelletier, J., Bruening, W., Kashtan, C. E., Mauer, S. M., Manivel, J. C., Striegel, J. E., Houghton, D. C., Junien, C., Habib, R., Fouser, L , Fline, R. N., Silverman, B. L., Haber, D. A., and Housman, D. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell, 67: 437-447, 1991.
72. Haber, D. A., Buckler, A. J., Glaser, T., Call, K. M., Pelletier, J., Sohn, R. L., Douglass, E. C., and Housman, D. E. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor Cell, 61: 1257-1269, 1990.
73. Maheswaran, S., Park, S., Bernard, A., Morris, J. F., Rauscher, F. J , Hill, D. E , and Haber, D. A. Interaction between the p53 and Wilms tumor (WT1) gene products: physical association and functional cooperation. Proc. Natl. Acad. Sci. USA, 90: 5100-5104, 1992.
74. Barr, F. G., Galili, N., Holick, J., Biegel, J. A., Rovera, G., and Emanuel, B. S. Rearrangement of the PAX3 paired box gene in the paediatric solid tumor alveolar rhabdomyosarcoma Nat. Genet., 3: 113-117, 1993
75. Galili, N., Davis, R. J., Fredericks, W. J., Mukhopadhyay, S., Rauscher, F. J., Emanuel, B. S., Rovera, G., and Barr, F. G. Fusion of a forkhead domain gene to PAX3 in the solid tumor alveolar rhabdomyosarcoma. Nat. Genet., 5: 230-235, 1993.
76. Shapiro, D. N., Sublett, J. E., Li, B., Downing, J. R., and Naeve, C. W., Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res., 53: 5108-5112, 1993.
77. Lai, E., Prezioso, V. R., Smith, E., Litvin, O., Costa, R. H., and Darnell, J. E. HNF-3A, a hepatocyte-ennched transcription factor of novel structure is regulated transcriptionally. Genes & Dev., 4: 1427-1436, 1990
78. Fredericks, W. J., Galili, N., Mukhopadhyay, S., Rovera, G., Benicelli, J., Barr, F. G., and Rauscher, F. J. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcoma is a more potent transcriptional activator than PAX3. Mol. Cell. Biol., 15: 1522-1535, 1995.
79. Chalepakis, G., Jones, F. S., Edelman, G. M., and Gruss, P. Pax-3 contains domains for transcription activation and transcription inhibition. Proc. Natl. Acad. Sci. USA, 91: 12745-12749, 1994.
80. Davis, R. J., D'Cruz, C. M., Lovell, M. A., Biegel, J. A., and Barr, F. G. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res., 54: 2869-2872, 1994.